OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy
Marco Gargaro, Giorgia Manni, Giulia Scalisi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4644-4644
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis
Lei Su, Yunhuan Gao, Rongcun Yang
Cells (2022) Vol. 11, Iss. 15, pp. 2296-2296
Open Access | Times Cited: 186

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
Florent Peyraud, Jean‐Philippe Guégan, Dominique Bodet, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 76

The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 21

An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002–2022): A medicinal chemistry perspective
Lin Li, Yue Dai, Yufeng Xia
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114845-114845
Closed Access | Times Cited: 38

Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
Yue Chen, Yadong Wang, Yawei Fu, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 30

Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer
Jing Yan, Di Chen, Zi Ye, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Closed Access | Times Cited: 8

Metabolic Implications of Immune Checkpoint Proteins in Cancer
Elizabeth R. Stirling, Steven M. Bronson, Jessica Mackert, et al.
Cells (2022) Vol. 11, Iss. 1, pp. 179-179
Open Access | Times Cited: 30

Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression
Karen McGovern, Alfredo Castro, Jill Cavanaugh, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 8, pp. 1261-1272
Open Access | Times Cited: 29

Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
Dongquan Xiang, Xin-Li Han, Jianxiong Li, et al.
Materials Today Bio (2023) Vol. 20, pp. 100675-100675
Open Access | Times Cited: 21

Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
Ion Negură, Mariana Pavel, Mihai Danciu
Cancer Treatment Reviews (2023) Vol. 120, pp. 102629-102629
Closed Access | Times Cited: 18

CAR-T Cell Therapy and the Gut Microbiota
Sahana Asokan, Nyssa Cullin, Christoph K. Stein‐Thoeringer, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 794-794
Open Access | Times Cited: 16

The Role of Gut Microbiota in Tumor Immunotherapy
Miao Wu, Jiawei Bai, Chengtai Ma, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 33

An integrated cytokine and kynurenine network as the basis of neuroimmune communication
Trevor W. Stone, Felix I. L. Clanchy, Yishu Huang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 27

The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection
P Oster, Laurie Vaillant, Brynn McMillan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23

Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases
Fatemah Bahman, Khubaib Choudhry, Fatema Al‐Rashed, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Deciphering the metabolic landscape of colorectal cancer through the lens of AhR-mediated intestinal inflammation
Jasmine Swain, Preeti Preeti, Chandana Mohanty, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer
Huizeng Wang, Bingchun Liu, Hong Chen, et al.
Genes and Environment (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 12

The Role of Microbiome in Nervous and Immune System Development
Hao Wang, Ji Young Lim, Qing Tang
Elsevier eBooks (2025)
Closed Access

Parabacteroides johnsonii Inhibits the Onset and Progression of Colorectal Cancer by Modulating the Gut Microbiota
Jing Liu, Yong Zhang, Li‐Yan Xu, et al.
Research Square (Research Square) (2025)
Closed Access

The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer
Sen Wang, Benling Xu, Yangyang Zhang, et al.
Cancer Biology and Medicine (2023), pp. 1-18
Open Access | Times Cited: 10

3,3′-Diindolylmethane and 1,4-dihydroxy-2-naphthoic acid prevent chronic mild stress induced depressive-like behaviors in female mice
Caitlin A. Madison, Jacob Kuempel, Georgia Lee Albrecht, et al.
Journal of Affective Disorders (2022) Vol. 309, pp. 201-210
Open Access | Times Cited: 14

TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) induces depression-like phenotype
Roanna A. Debler, Paula L. Gallegos, Alexandra C. Ojeda, et al.
NeuroToxicology (2024) Vol. 103, pp. 71-77
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top